{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:27:53Z","timestamp":1792038473372,"version":"4.4.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>A retrospective study which analyzed the data of female patients attending a tertiary care center in National Capital Territory for the treatment of endometrial cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Eighty-six histopathologically confirmed cases of carcinoma endometrium were taken from January 2016 to December 2019. Detailed information was collected regarding patient\u2019s case history, sociodemographic data (age of presentation, occupation, religion, residence, and substance addiction), clinical presentation, diagnostic and therapeutic procedures, and known risk factors (age at menarche and menopause, parity, obesity, use of oral contraceptive pills, hormone replacement therapy, and comorbidities such as hypertension and diabetes).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>After analysis, results were presented as mean \u00b1 standard deviation and frequency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Eighty-six percent of the patients (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 73) were in the age group of 40\u201370 years; the mean age of the patients at diagnosis of endometrial cancer was 54 years. Eighty-one percent (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 70) of the patients were from urban areas. Sixty-seven percent of the females (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 54) were Hindu. All the patients were housewives with nonsedentary lifestyles. Most patients (88%; n = 76) presented with bleeding per vaginum. Fifty-nine percent (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 51) had stage I disease, followed by 15% (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 13) with stage II, 14% (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 12) with stage III, and 12% (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 10) with stage IV disease. Eighty-two percent (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 72) of the patients had endometrioid carcinoma. Other less common variants were mixed Mullerian malignant tumor, squamous, adenosquamous, serous, and endometrioid stromal. Forty-four percent (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 38), 39% (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 34), and 16% (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 14) of the patients had grade I, grade II, and grade III tumor, respectively. 53.5% of the cases (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 46) had &gt;50% myometrial invasion at the time of presentation. Eighty-two percent (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 71) of the patients were postmenopausal. The mean age at menarche and menopause was 13 years and 47 years, respectively. Fifteen percent (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 13) of the females were nulliparous. Forty-six percent (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 40) of the patients were overweight. Most patients (82%) had no history of addiction. Twenty-five percent (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 22) of the patients had hypertension, and 27% (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 23) has diabetes as comorbidity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The incidence of endometrium cancer is showing a steady rise in the recent past. Early age of menarche, late age of menopause, nulliparity, obesity, and diabetes mellitus are well-documented risk factors for uterine cancer. Better outcome and control of disease is possible by understanding of endometrial cancer etiology, risk factors, and its preventive measures. Thus, a robust screening program is warranted to detect the disease in early stage and for increased survival.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_2029_21","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T01:12:07Z","timestamp":1686618727000},"page":"452-456","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":27,"title":["Epidemiological characteristics of endometrial cancer patients treated at a tertiary health center in National Capital Territory of India"],"prefix":"10.4103","volume":"19","author":[{"given":"Shruti","family":"Agarwal","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wineeta","family":"Melgandi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak Raj","family":"Sonkar","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiz Akram","family":"Ansari","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savita","family":"Arora","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun Kumar","family":"Rathi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishore","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"R1-20241021","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20241021","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1158\/1055-9965.EPI-16-0858","article-title":"Global cancer in women:Burden and trends","volume":"26","author":"Torre","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R3-20241021","first-page":"7","article-title":"Retrospective clinico-epidemiological study of endometrial carcinoma, mansoura experience","volume":"3","author":"Elissawy","year":"2020","journal-title":"Asian Oncol Res J"},{"key":"R4-20241021","first-page":"179384","article-title":"Hospital-based study of epithelial malignancies of endometrial cancer frequency in lahore, pakistan, and common diagnostic pitfalls","volume":"2014","author":"Tanvir","year":"2014","journal-title":"Patholog Res Int"},{"key":"R5-20241021","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/jnci\/59.4.1055","article-title":"Epidemiology of endometrial cancer","volume":"59","author":"Elwood","year":"1977","journal-title":"J Natl Cancer Inst"},{"key":"R6-20241021","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/oxfordjournals.aje.a113417","article-title":"Acase-control study of cancer of the endometrium","volume":"116","author":"Kelsey","year":"1982","journal-title":"Am J Epidemiol"},{"key":"R7-20241021","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0277-5379(88)90251-9","article-title":"The joint effect of risk factors on endometrial cancer","volume":"24","author":"Ewertz","year":"1988","journal-title":"Eur J Cancer Clin Oncol"},{"key":"R8-20241021","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0002-9378(11)91709-8","article-title":"Reproductive, menstrual, and medical risk factors for endometrial cancer:Results from a case-control study","volume":"167","author":"Brinton","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20241021","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet"},{"key":"R10-20241021","doi-asserted-by":"crossref","first-page":"937","DOI":"10.5114\/aoms.2010.19305","article-title":"Long-term survival of endometrioid endometrial cancer patients","volume":"6","author":"Gottwald","year":"2010","journal-title":"Arch Med Sci"},{"key":"R11-20241021","first-page":"23","article-title":"Implementation of laparoscopic surgery for endometrial cancer:Work in progress","volume":"8","author":"Van den Bosch","year":"2016","journal-title":"Facts Views Vis Obgyn"},{"key":"R12-20241021","doi-asserted-by":"crossref","first-page":"44","DOI":"10.21315\/mjms2016.23.6.5","article-title":"Median survival time of endometrial cancer patients with lymphovascular invasion at the hospital Universiti Sains Malaysia","volume":"23","author":"Asyikeen","year":"2016","journal-title":"Malays J Med Sci"},{"key":"R13-20241021","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/COC.0b013e318277d5f4","article-title":"Impact of comorbid conditions on survival in endometrial cancer","volume":"37","author":"Nicholas","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"R14-20241021","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1186\/s12885-019-5748-4","article-title":"The effect of diabetes on the risk of endometrial cancer:An updated a systematic review and meta-analysis","volume":"19","author":"Saed","year":"2019","journal-title":"BMC Cancer"},{"key":"R15-20241021","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/ijc.31961","article-title":"Risk factors for endometrial cancer:An umbrella review of the literature","volume":"145","author":"Raglan","year":"2019","journal-title":"Int J Cancer"},{"key":"R16-20241021","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.puhe.2015.04.017","article-title":"The effect of body mass index on endometrial cancer:A meta-analysis","volume":"129","author":"Jenabi","year":"2015","journal-title":"Public Health"},{"key":"R17-20241021","first-page":"2950","article-title":"Obesity as a significant risk factor for endometrial cancer","volume":"5","author":"Suskic","year":"2016","journal-title":"IJRCOG"},{"key":"R18-20241021","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ygyno.2011.01.027","article-title":"Obesity in relation to endometrial cancer risk and disease characteristics in the women's health initiative","volume":"121","author":"Reeves","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R19-20241021","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.5301\/JBM.5000047","article-title":"Overweight, obesity and endometrial cancer risk:Results from a systematic review and meta-analysis","volume":"29","author":"Zhang","year":"2014","journal-title":"Int J Biol Markers"},{"key":"R20-20241021","first-page":"1305","article-title":"Overall survival and disease-free survival in endometrial cancer:prognostic factors in 276 patients","volume":"6","author":"Tejerizo-Garc\u00eda","year":"2013","journal-title":"Onco Targets Ther"},{"key":"R21-20241021","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.7314\/APJCP.2014.15.5.2279","article-title":"Long term outcomes of patients with endometrial carcinoma treated with radiation \u2013Siriraj Hospital experience","volume":"15","author":"Setakornnukul","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"R22-20241021","doi-asserted-by":"crossref","first-page":"012","DOI":"10.17352\/anpc.000019","article-title":"Survival determinants in endometrial cancer patients:5-years experience","volume":"3","author":"Pinar","year":"2017","journal-title":"Arch Nurs Pract Care"},{"key":"R23-20241021","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.7150\/jca.15037","article-title":"Body mass index is positively associated with endometrial cancer in Chinese women, especially prior to menopause","volume":"7","author":"Gao","year":"2016","journal-title":"J Cancer"},{"key":"R24-20241021","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/ajcp\/77.5.534","article-title":"Carcinoma of the endometrium. II. Papillary adenocarcinoma:A clinical pathological study, 46 cases","volume":"77","author":"Christopherson","year":"1982","journal-title":"Am J Clin Pathol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2029_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:38:33Z","timestamp":1787067513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2029_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_2029_21","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"2021-11-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}